After the development of resistance to BRAF/MEK inhibitors, these resistant melanoma cell lines are susceptible to pyroptosis, which can be induced by etoposide or doxorubicin [74], and the combination of temozolomide and chloroquine [75]. Here, MAP2K7 is linked to melanoma.